Ultrasound vendor Acoustic Imagingis still open for business, contrary to a rumor that swept throughthe industry late last month hinting that the Phoenix-based companyhad closed its doors. The firm enjoyed a strong September andis looking forward to the
Ultrasound vendor Acoustic Imagingis still open for business, contrary to a rumor that swept throughthe industry late last month hinting that the Phoenix-based companyhad closed its doors. The firm enjoyed a strong September andis looking forward to the Radiological Society of North Americameeting this month, according to president John Kingsley.
The last several years have been bumpy for AI. The companyhas frequently been the target of rumors that its parent, DornierMedical Systems, is close to selling off the firm. Dornier boughta controlling interest in AI in 1989 (SCAN 9/27/89).
Kingsley came on board in 1993 in a restructuring that sawthe firm trim its payroll and focus on cost-effective systemslike its Performa scanner, released last year (SCAN 2/24/93 and12/29/93). Those efforts have paid off, and this year AcousticImaging's sales are progressing well and the company is aheadof its business plan, Kingsley said.
"We had the best month (in September) since I've beenon board," Kingsley said. "I don't see (the rumor's)foundation in fact, unless we're making a few people nervous."
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.